Cite
HARVARD Citation
Naing, A. et al. (2020). Phase 2 study of pembrolizumab in patients with advanced rare cancers. Journal for immunotherapy of cancer. 8 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Naing, A. et al. (2020). Phase 2 study of pembrolizumab in patients with advanced rare cancers. Journal for immunotherapy of cancer. 8 (1), p. . [Online].